Arr, ye scurvy dogs! VKA be crushin' NOAC in frail AF swabbies. Give 'em therapy, or walk the plank!
2023-09-11
Ye scurvy dogs who be sufferin' from the cursed atrial fibrillation, be warned! Switchin' yer treatment to a newfangled NOAC agent may cause ye to bleed like a leaky barrel! No treasure in terms of thromboembolic events be found, mateys!
Arr, me hearties! Listen up, ye scurvy dogs, for I have news that be both curious and amusing! It seems that frail landlubber patients sufferin' from atrial fibrillation, a condition that makes their hearts dance a jig, were subjected to a risky experiment. These poor souls were made to abandon the tried and true vitamin K antagonists in favor of a newer agent known as a NOAC.Now, ye might be wonderin', "What be a NOAC, ye salty sea dog?" Well, it stands for non-vitamin K oral anticoagulant, a fancy term for a newfangled blood-thinner. But here be the rub, me hearties! This study, carried out by the clever folks at Medscape Medical News, found that these frail patients who jumped ship to the NOAC had more bleedin' than those poor souls who stuck with the old vitamin K antagonists.
Arr, it be a sorry sight indeed! These poor souls were bleedin' like a leaky barrel of grog, yet there was no benefit in terms of thromboembolic events! Throm-what? I hear ye ask. Well, it be a fancy way of sayin' blood clots, me hearties. So while these poor souls were sufferin' from an endless flow of blood, their risk of blood clots remained unchanged!
Now, ye might be thinkin', "Why in Davy Jones' locker would they switch to this newfangled NOAC if it be causin' more bleedin' with no benefits? Are they daft?" Well, me mateys, that be a question for the scallywags who conducted the study. Perhaps they be lookin' to shake things up, or maybe they be havin' a bit of fun at the expense of these frail patients!
So, me hearties, let this be a lesson to ye all: sometimes, the old ways be the best ways. Stick with the tried and true, and avoid the temptations of the shiny and new. And as for these frail patients, may they find their way back to the safe harbor of the vitamin K antagonists, where bleedin' be low and blood clots be scarce!